Loading provider…
Loading provider…
Hematology & Oncology Physician in Cleveland, OH
NPI: 1457319717Primary Practice Location
CLEVELAND CLINIC
9500 Euclid Ave, Cleveland, OH
Primary Employer
Cleveland Clinic
clevelandclinic.org
HQ Phone
Get M.D. Hetty's Phone NumberMobile
Get M.D. Hetty's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
OH State Medical License
2013 - 2027
MD State Medical License
2001 - 2026
Johns Hopkins University
2004 - 2008
2004 - 2008
Fellowship • Hematology and Medical Oncology
2001 - 2005
Residency • Internal Medicine
1998 - 2001
Johns Hopkins Carey Business School
Business
2004 - 2006
UMass Chan Medical School
umassmed.edu
Medical School
Until 1998
Brandeis University
B.A. • Biology & Neuroscience
1989 - 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 44 | 140 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 20 | 111 |
| 3 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 16 | 28 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 14 | 18 |
Current and emerging strategies for management of myelodysplastic syndromes.
Authors: Saygin, Caner, Carraway, Hetty E
Journal: Blood Rev
Publication Date: 2020-12-27
Lead Sponsor: Mikkael Sekeres, MD
Collaborators: Bristol-Myers Squibb, Celgene
Intervention / Treatment: DRUG: Lenalidomide, DRUG: Luspatercept
Lead Sponsor: Syros Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Azacitidine, DRUG: Tamibarotene
Lead Sponsor: Immune-Onc Therapeutics
Collaborators: California Institute for Regenerative Medicine (CIRM)
Intervention / Treatment: BIOLOGICAL: IO-202, BIOLOGICAL: IO-202 and Azacitidine, BIOLOGICAL: IO-202 and Azacitidine + Venetoclax